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A BSTR ACT 
5,6-Dichloro-l-/~-o-ribofuranosylbenzimidazole (DRB) inhibits  RNA synthesis in 
L-929 cells (mouse fibroblast line) and  HeLa cells (human epithelioid carcinoma 
line) within 2 min of addition of the compound to the medium. By removing DRB 
from  the  medium,  the  inhibition  is  promptly  and  completely  reversed  after 
treatment of cells for as long as I h or even longer. The inhibitory effect of DRB on 
the overall rate of RNA synthesis is similar in L  and HeLa ceils and is markedly 
concentration-dependent  in the low dose range (5-20 #M  or  1.6-6.4/~g/ml),  but 
not  at  higher concentrations of DRB.  At a  concentration  of  12 #M,  DRB has a 
highly selective inhibitory effect on the synthesis of nuclear heterogeneous RNA in 
L  cells.  At  higher  concentrations,  there  is  also  inhibition  of  45  S  ribosomal 
precursor  RNA  synthesis,  but  at  all  concentrations  the  effect on heterogeneous 
RNA synthesis in L cells in considerably greater than that on preribosomal RNA 
synthesis.  In HeLa cells,  too,  DRB has a  selective effect on heterogeneous RNA 
synthesis, but quantitatively the selectivity of action is somewhat less pronounced. 
In  both  L  and  HeLa cells,  the  inhibition  of synthesis  of nuclear  heterogeneous 
RNA  is  incomplete  even  at  very high  concentrations  of DRB  (150  ~zM). Thus, 
while DRB is a selective inhibitor of nuclear heterogeneous RNA synthesis, not all 
such  RNA  synthesis  is  sensitive  to  inhibition.  It  is  proposed  that  messenger 
precursor  RNA  synthesis  may  largely  be  sensitive  to  inhibition  by  DRB.  In 
short-term experiments, DRB has no effect on protein synthesis in L or HeLa cells. 
DRB has a slight to moderate inhibitory effect on uridine uptake into L cells and a 
moderate to marked effect on uptake of uridine  into  HeLa cells. 
Ribosides of halobenzimidazoles are highly active 
inhibitors of the multiplication of RNA (3,  13, 27, 
29,  30)  and  DNA  (16,  31,  32)  viruses  and  of 
cellular RNA synthesis (3,  14, 31). The inhibitory 
activity of such derivatives increases with multiple 
substitution of halogen atoms in the benzenoid  ring 
(27, 28,  29). Of special interest is the fact that the 
highest  inhibitory  activity  is  obtained  when  the 
carbohydrate moiety is identical  with that present 
in RNA. Any departure from the B-o-ribofuranose 
structure in the  benzimidazole glycoside  results in 
reduced  inhibitory activity (27  29). The influenza 
virus  growth  cycle  is  sensitive  to  inhibition  by 
5,6-dichloro- l-B-D-ribofuranosylbenzimidazole 
(DRB) (31)  and a-amanitin (18)  only during  the 
first 2-3 h from infection.  This and other evidence 
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plication of myxoviruses. 
It was demonstrated early that DRB retards the 
proliferation  of  cells  in  culture  (16,  29).  Upon 
removal of the compound (73 #M DRB), prolifera- 
tion  of  chorioallantoic  membrane  cells  rapidly 
reached the degree shown by controls (29). These 
and other observations suggested  that  DRB  may 
reversibly reduce the rate of nucleic acid metabo- 
lism rather than cause irreversible changes in the 
biosynthetic machinery  of  the  cells  (29,  33).  In 
rhesus monkey kidney cells,  in vitro microscopic 
changes could be detected after treatment of cells 
with 40 uM  DRB for 48 h, but these changes did 
not progress with time (30).  At higher DRB con- 
centrations, the morphological changes were  pro- 
gressive. 
The early work was followed  by the demonstra- 
tion that DRB inhibits RNA synthesis in isolated 
calf thymus  nuclei (2)  and  in  the  chick  chorio- 
aUantoic membrane and  monkey kidney cells  in 
vitro (31).  In cell experiments in which incorpora- 
tion of precursors was observed for a period of 3 
h,  approximately 60%  inhibition of adenosine in- 
corporation  into RNA  was  associated  with  20% 
inhibition of alanine incorporation into proteins. 
DRB was employed at a concentration of 55 uM 
in  the  chorioallantoic membrane and  at  95  uM 
DRB  in  monkey  kidney  cells  (31).  Sirlin  and 
Jacob  (25)  then  observed  that  DRB  markedly 
inhibits chromosomal RNA synthesis in the  sali- 
vary  gland  cells  of  the  chironomid  Smittia 
parthenogenetica  while causing little inhibition of 
nucleolar RNA  synthesis. Previously it had  been 
reported  that,  in the  isolated calf thymus nuclei, 
DRB had a greater inhibitory effect on nucleolar 
than on nucleoplasmic RNA synthesis (I). 
There is now considerable evidence that 60 ,M 
DRB  selectively inhibits heterogeneous high  mo- 
lecular weight  RNA synthesis in the salivary gland 
cells of Chironomus tentans  and has no detectable 
effects  on the synthesis of nucleolar preribosomal 
RNA  or  4  S  RNA  (7,  8,  10,  11,  21).  At higher 
concentrations, DRB  also  inhibits nucleolar pre- 
ribosomal RNA and 4 S RNA synthesis. Egyh~zi 
(9)  has  presented  data  suggesting that  at  lower 
concentrations there is a selective  effect on initia- 
tion  of  chains  of  heterogeneous  high  molecular 
weight  RNA.  Granick (14,  15)  has  observed  in 
chick  embryo  fibroblast cells that  156 ~tM  DRB 
has a greater effect  on the synthesis of heterogene- 
ous  nuclear RNA  and  messenger RNA  than  on 
ribosomal precursor RNA or tRNA synthesis. 
Recently,  DRB  has  been  shown  to  cause  a 
marked  increase  in  interferon  production  in  a 
strain  of  diploid  human  fibroblasts (FS-4  cells) 
after  induction by polyinosinic:polycytidylic  acid 
(poly  I:C)  (22,  23).  There  is  a  close  correlation 
between  the  superinducing  effect  of  DRB  on 
interferon production and inhibition of RNA syn- 
thesis.  DRB  blocks  a  control  mechanism which 
ordinarily shuts  off interferon production within 
6-8 h after induction of cells with poly I:C (22, 23). 
At the same time, evidence has been obtained that 
DRB  is  also  capable  of  inhibiting  interferon 
mRNA synthesis (24). 
We  have  carried  out  an  investigation of  the 
action of DRB  in the  L-929  line of mouse fibro- 
blasts  and  in  HeLa  cells  derived  from  a  human 
cervical  carcinoma.  We  have  investigated dose- 
response relationships and the kinetics of action of 
DRB.  The effects  of DRB on nucleoplasmic and 
nucleolar RNA  synthesis have  been determined. 
We have also investigated the effect of DRB on the 
uptake of [3H]uridine into cells. 
MATERIALS AND  METHODS 
Cell Culture 
Two continuous lines of cells were used. The L-929 
mouse fibroblasts were grown in monolayer culture in 
Eagle's minimal essential medium (MEM) (6) with 5% 
fetal calf serum. For  some experiments, L cells were 
grown in suspension culture in the spinner modification 
of  MEM  with 7%  fetal calf serum. HeLa $3  human 
epithelioid  carcinoma cells were grown and maintained in 
suspension culture in the spinner modification of MEM 
with 7% calf serum. For some experiments, HeLa cells 
were  planted  in  plastic  dishes  in  reinforced  Eagle's 
medium with 10% calf serum. 
Chemicals and Buffers 
[sH]Uridine (21.0-29.65 Ci/mmol) and  [SH]leu6ine 
(47  Ci/mmol) were obtained from New  England Nu- 
clear,  Boston, Mass. DRB was obtained from Merck, 
Sharp  and  Dohme Research Laboratories  (Rahway, 
N.  J.) through the courtesy of Dr.  Arthur F. Wagner. 
Phosphate-buffered saline (PBS), contains 0.13 M NaCI, 
0.0027  M  KCI, 0.00082  M  Na2HOP,,  0.0015  M 
KH2PO,, 0.00091 M CaCI2 and 0.0005 M MgCi2, and 
the pH is 7.3. RSB is 0.01 M KCI, 0.0015 M MgCI~,  0.01 
M tris (hydroxymethyl)aminomethane, pH 7.4. HSB is 
0.5 M NaCI, 0.05 M MgC12, and 0.01 M tris. SSE is0.15 
M  NaCI, 0.015 M  sodium citrate,  0.01 M  disodium 
ethylenediaminetetraacetate  (EDTA).  SDS  buffer  is 
0.5% sodium dodecyl sulfate, 0.1  M  NaCI,  0.001 M 
EDTA, 0.01 M tris, pH 7.4. 
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In most experiments, cells in logarithmic growth were 
pulse-labeled  with  2.5  ,Ci/ml  [SHJuridine  for  15  min. 
Commonly,  treatment  with  DRB  was  begun  15  min 
before the pulse and continued during the pulse. After the 
pulse, the cells were washed four times with ice-cold PBS, 
collected,  and  suspended  in  5%  trichloroacetic  acid 
(TCA). Aliquots of the suspension were placed on GF/C 
filters for determination of total cell-associated radioac- 
tivity in a  liquid scintillation spectrometer. The remain- 
der was filtered and the precipitate was washed with 5% 
TCA, dried,  and counted to determine acid-precipitable 
radioactivity. To determine the effect of DRB on RNA 
synthesis, the acid-precipitable counts were corrected for 
the effect of DRB on uptake of [SH]uridine into cells (22) 
as follows: a ratio, expressed as a percentage of precipita- 
ble to total  counts was calculated for each sample, and 
then the ratios in experimental samples were divided by 
those  in  controls,  giving  estimates  of  rates  of  RNA 
synthesis as a percentage of control rates. An alternative 
approach (14), which gives the same result, is to calculate 
for each pair of data from a treated and a control group a 
ratio  for  precipitable  counts, a  ratio  for  counts in  the 
acid-soluble pool, and a ratio of the two, which then gives 
an estimate of RNA synthesis in the treated vs. control 
group.  It  is  assumed  that  DRB  does  not  alter  the 
processing of uridine after transport of the precursor into 
cells and that the uridine pool is not compartmentalized. 
In  some  experiments,  an  aliquot  of the  collected  cell 
suspension from groups of three or four cultures was used 
for protein determination according to Lowry et al. (17). 
Isolation of Cell Nuclei and of the 
Nucleoplasmic and Nucleolar Fractions 
Cells  were  harvested  by  centrifugation,  washed  with 
PBS,  and  nuclei  were  isolated  by  the  procedure  of 
Penman (19), with minor modifications. In brief, L cells 
were  resuspended for a  minimum of 10 min in  2  ml of 
one-half strength  RSB  on  ice.  HeLa  cells  were  resus- 
pended for a  minimum of 15 min in RSB. The cells were 
ruptured in a  Dounce homogenizer with 20 strokes. The 
nuclei were pelleted by centrifugation, washed once with 
RSB, and resuspended in 2 ml RSB or one-half strength 
RSB. A mixture of NP-40 and sodium deoxycholate was 
then  added  and the suspension shaken in a  vortex-type 
mixer.  The  nuclei  were  collected  by  centrifugation, 
resuspended in 2  ml of HSB  and digested with  DNAse 
(25  /zl  of  a  2  mg/ml  solution)  for  10  min  at  room 
temperature.  The  nucleoli  and  nucleoplasm  were  then 
separated by zonal centrifugation. The nuclear digest was 
layered on 2.5 ml of 30% sucrose in HSB and centrifuged 
at  23,000  rpm  for  10 rain  in an SW-56 Beckman rotor 
(Beckman  Instruments,  Inc.,  Spinco  Div.,  Palo  Alto, 
Calif.). The nucleoplasmic components in the supernate 
were collected, precipitated with two volumes of ethanol, 
and pelleted by centrifugation. This nucleoplasmic pellet 
and the nucleolar pellet from sucrose gradient separation 
were  resuspended in SDS  buffer.  10-,1 aliquots of each 
were placed on GF/C  filters and counted after drying to 
obtain  estimates of inhibition  of nucleoplasmic vs.  nu- 
cleolar  RNA synthesis by DRB. 
The  nucleoplasmic  and  nucleolar  fractions  were 
brought to  a  final concentration  of 0.01  M  EDTA  and 
shaken with phenol saturated with SSE. Then, a volume 
of chloroform equal to the volume of phenol was added, 
and the mixture shaken again.  After centrifugation, the 
aqueous  phase  and  the  interphase  were  collected  and 
extracted with chloroform. After another centrifugation, 
only the aqueous phase was collected, washed with ether 
three times, and the other removed with N2.  RNA was 
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FIGURE  1  Relation between concentration of DRB and 
effects on  [*H]uridine  uptake  and  RNA  synthesis in  L 
cells. L cells were planted in 60-mm plastic petri dishes at 
a  concentration  of  2.5  ￿  10 ~  ceils/plate  in  Eagle's 
MEM  with 5%  fetal calf serum. 24 h  later,  the incom- 
plete monolayers of L cells were washed once with warm 
Eagle's medium and incubated at 37~  for  15 min with 
DRB  at  varying concentrations in serum-free MEM,  5 
ml/plate. Controls received no DRB. Three dishes were 
used per  variable.  The cultures were then pulse-labeled 
for  15 min with [SHJuridine added  in a  vol of 100 #1 to 
give 2.5/zCi/ml.  In the  DRB-treated  cultures the com- 
pound remained present during the pulse. After the pulse, 
the medium was  aspirated  and the dishes were  washed 
and  frozen.  Subsequently,  1  ml  of distilled  water  was 
added  per dish and the cells scraped off with a  silicone 
square. The plates then received  1 ml of 10% TCA. Two 
aliquots  of  10 ,I  each  were  used  for determination  of 
total  cell-associated  radioactivity.  The  remainder  was 
used to measure acid-precipitable radioactivity. To deter- 
mine  the  effect  of  DRB  on  RNA  synthesis, the  acid- 
precipitable  cpm  were  corrected  for  effect  of DRB  on 
uptake of [~H]uridine into cells as described in Materials 
and  Methods.  Mean  results  of  two  experiments  are 
shown. In the untreated controls, the total radioactivity 
was  83,053  cpm and  the acid-precipitable  radioactivity 
was  5,976  cpm.  (O  --O),  Total  cellular  uptake  of 
[SH]uridine;  (+  +),  RNA  synthesis; (0 .... 0),  in- 
corporation  of [SH]uridine  into  acid-precipitable  mate- 
rial. 
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FIGURE  2  Kinetics of action  DRB  on  [3H]uridine  uptake  and  RNA  synthesis in  L  cells.  Monolayer 
cultures of L cells (see Fig.  l) were incubated with  30/aM  DRB and [SH]uridine,  2.5/aCi/ml. Controls 
received no DRB. At intervals,  three experimental and three control dishes were collected and processed for 
determination  of  total  uptake  of  [SH]uridine  into  cells  and  of  incorporation  of  [3H]uridine  into 
acid-precipitable material.  Mean  results of four experiments are  shown.  (A) Total  cellular  uptake  of 
[~H ]uridine; (&  &), control; (A ....  A), 30/aM  DRB. (B) Incorporation of [aH]uridine into acid-precipi- 
table material; ￿9  ￿9  control; (V ....  V), 30/aM  DRB. (C) Effects of DRB expressed as % of control; 
(O---O), total uptake of [3H]uridine;  (+  +), RNA synthesis; (O  ....  0), incorporation of [SH]uridine 
into  acid-precipitable  material  (cpm);  (i ....  M),  incorporation  of  [SH]uridine  into  acid-precipitable 
material (cpm/mg protein). 
TABLE  l 
Reversibility of the Inhibitory Effect of 60 ~aM DRB on Uridine Incorporation  in L Cells in 
Monolayer 
Medium 
During 
Before  15-rain 
pulse  pulse  {*HlUridinr incorporation* 
ug  cpmh*g  % of 
cpm  protein  protein  control 
Control  Control  2,295  89  25.8  100 
DRB, 60 rain  DRB  882  89  9.9  38 
DRB, 60 min  Control  2,249  72  31.2  121 
*  60-mm plastic petri dishes were seeded with 2.5  ￿  10 ~ L cells per dish in MEM with 5% fetal 
calf serum. Approximately 22 h later, the medium was removed and the incomplete monolayers 
of L cells were incubated with or without 30/aM  DRB in MEM without serum. The medium 
was then  replaced with  either control or  DRB-containing medium, and  [SH]uridine  (sp  act 
29.65 Ci/mmol) was  added to a concentration of 2.5/aCi/ml for pulse-labeling.  [sH]Uridine 
incorporated into acid-precipitable material was determined and expressed in cpm/mg protein. 
then precipitated with  2.5  vol of ethanol and stored at 
-20~C until  analyzed by gel electrophoresis. 
Gel Electrophoresis 
For the analysis of RNA  in the nucleoplasmic frac- 
tion, gels of 9 cm containing 1.0% polyacrylamide and 
1.0% agarose were prepared according to the procedure 
of Watanabe and co-workers (34). During  electrophore- 
sis  the gels  were  held in  glass tubes with  nylon mesh. 
Electrophoresis was carried out for 3-3.5 h at a current 
of 5 mA per gel and a potential gradient of 20 V/cm. The 
runs  were  terminated when  the tracking  dye (bromo- 
phenol blue) had migrated 75% of the length of the gel. 
The  gels  were  extruded  from  tubes directly  into  l-ml 
tuberculin  syringes.  Each  gel  was  extruded  from  the 
tuberculin syringe through a 20-gauge needle and 1.5-mm 
fractions were  collected.  For  analysis of RNA  in  the 
nucleolar fraction, gels of 10 cm containing 2.0% poly- 
acrylamide and 1% agarose were prepared. Electrophore- 
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into  I-ram  fractions  with  a  multiple  wire  slicer.  The 
fractions  were  prepared  for  scintillation  counting  with 
water  and  NCS  solubilizer (Amersham/Searle  Corp., 
Arlington  Heights,  IlL)  according to  the  procedure  of 
Fromageot and Zinder (12). 
RESULTS 
Action  of DRB  in L  Cells 
DOSE-EFFECT  RELATIONSHIPS:  The effects 
of DRB on total uptake of uridine and on incorpo- 
ration  into  acid-precipitable  material  were deter- 
mined in experiments in which L cells were treated 
with  the  compound  at  varying concentrations  for 
15 min and then pulse-labeled with [3H]uridine, 2.5 
/~Ci/ml,  for  15  min  in  the  continued  presence  of 
DRB.  Estimates  of the  effect on  RNA  synthesis 
were derived by correction of the data as described 
in  Materials  and  Methods. 
Fig.  1 shows  that  30-90  uM  DRB (9.6  -  28.7 
#g/ml)  has  only  a  slight  to  moderate  inhibitory 
effect  on  uptake  of  [3H]uridine  into  L  cells. 
Inhibition  of cellular  RNA  synthesis  by  DRB  is 
markedly concentration-dependent  in the very low 
dose  range  and  there  is little increase in effect at 
concentrations  higher  than  30  uM.  It  is  evident 
that a  part  of RNA synthesis is highly sensitive to 
inhibition  by  DRB,  as  the  rate  is  reduced  to 
approximately  60% of control rate by  12 ~tM  (3.8 
#g/ml)  DRB.  However, even at  90 ~zM  DRB the 
rate  of  RNA  synthesis  is  49%  of control  value, 
indicating  the  presence  of  a  fraction  resistant  to 
inhibition  by DRB. 
In experiments on protein synthesis, using pulse- 
labeling  with  [SH]leucine,  DRB  did  not decrease 
incorporation  into acid-precipitable material. This 
is  in  agreement  with  results  obtained  in  human 
foreskin  (FS-4)  cells,  in  which  no  inhibition  was 
observed when protein synthesis was measured 0.5 
h  after  DRB treatment  at concentrations  up to 60 
#M (22). After 5 h of treatment, the rate of protein 
synthesis  was  moderately  inhibited  at  DRB  con- 
centrations of 20/zM  and  higher (22). This inhibi- 
tion is probably  secondary to prolonged inhibition 
of RNA synthesis. The rate of RNA synthesis was 
inhibited to a  similar extent at 0.5  and 5.0 h after 
DRB treatment of FS-4 cells; there was no signifi- 
cant inhibition  at 5.0 ~tM  DRB and  60-70%  inhi- 
bition at 60 #M  DRB concentration  (22). 
KINETICS  OF  ACTION:  Fig.  2  summarizes 
results  of  experiments  in  which  both  the  total 
uptake  of [3H]uridine  and  incorporation  into acid 
precipitable material  were followed over a  12-min 
period from addition of 30 ~M  DRB and  [SH]uri- 
dine  to  monolayer  cultures  of  L  cells.  Fig.  2  A 
shows that total uptake was essentially linear from 
0  time and  that  uptake  was  somewhat  reduced  in 
the presence of DRB. The results in Fig. 2 B show 
that  incorporation  of  uridine  into  acid-insoluble 
material  by L  cells attains  an apparently constant 
and  maximal  rate  within  a  few  minutes  after 
addition  of uridine  to  the  medium,  as  had  been 
reported  previously  for  Novikoff  rat  hepatoma 
cells growing in suspension culture (20).  It can also 
be  seen  that  DRB  inhibits  RNA  synthesis within 
2  min of addition  of the compound to the culture 
medium.  In one experiment, the effect of DRB was 
determined  1 min after addition, and the degree of 
inhibition observed  at  I  min was not significantly 
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Effects DRB on nucleoplasmic and nucleolar 
RNA  synthesis  in  L  cells.  L  cells  from  monolayer 
cultures were grown for 2 days in suspension  culture in 
spinner modification of MEM with 7% fetal calf serum. 
Initial cell concentration was 2  ￿  105 cells/ml, and the 
vol was in the range of 200 ml. The cell concentration was 
maintained  between  2  and  4  ￿  105  cells/ml by daily 
dilution.  The  harvested  cells  were  washed  once  with 
warm medium and distributed among six aliquots of 50 
ml each containing 4  ￿  106 eells/ml (2  ￿  107 aliquot). 
Cells were incubated at  37~  for  15 min in serum-free 
MEM or in medium containing DRB at varying concen- 
trations.  [sH]Uridine,  15 uCi/ml, was then added  for a 
pulse  of 15 min. After labeling, the cells were harvested 
on ice, collected by centrifugation, and washed once with 
PBS. The nuclei and then the nucleoplasmic and nucleo- 
lar fractions were isolated as described  in Materials and 
Methods. Incorporation of [SH]uridine  into acid-precipi- 
table  material  in the nucleoplasmic and  nucleolar frac- 
tions  was  determined.  Results  of  12  experiments  are 
shown.  In the untreated controls, the mean radioactivity 
in the nucleoplasmic fraction was 974,100 cpm and in the 
nucleolar fraction it was  598,300  cmp.  (1  1),  Nu- 
cleoplasmic fraction; (& .... &), nucleolar fraction. The 
vertical  bars  indicate  probable  error  for  data  points. 
Results of a single experiment are given for 90/~M DRB. 
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FIGURE 4  Effects of DRB on the synthesis  of nuclear heterogeneous and ribosomal precursor RNA in L 
cells.  The  experimental  conditions  are  given in  Fig.  3.  The  isolation  of nucleoplasmic and  nucleolar 
fractions and  of RNA from such fractions as well as the procedure for acrylamide gel electrophoresis are 
described in Materials and Methods. (A) Nucleoplasmic RNA, control; (B) nucleolar RNA, control; (C) 
nucleoplasmic RNA,  12 ~.M DRB; (D) nucleolar RNA,  12 ~M DRB. 
different from that observed at 2-12 min. Fig. 2 C 
illustrates the constancy of the inhibitory effects of 
DRB over a 2  12 min period from the beginning of 
treatment. 
Experiments  were  also  done  to  follow the  ki- 
netics of DRB  action  over longer periods.  Mono- 
layer cultures of L cells were incubated with 30 #M 
DRB for intervals ranging from  10 to 60 min and 
then  pulse-labeled  for  10  min  with  [SH]uridine. 
The  inhibitory  effect of DRB on  RNA  synthesis, 
established  within  15  min  from  the  onset  of 
treatment,  became only slightly more marked over 
the subsequent  50-min period. The slight effect of 
30 ~M  DRB on uridine uptake into cells remained 
essentially  unchanged  over  the  course  of such  a 
treatment  period. 
REVERSIBILITY"  We  have  investigated  the 
reversibility  of  the  inhibitory  action  of  DRB  in 
experiments in which monolayer cultures of L cells 
were treated with DRB for varying periods and at 
varying  concentrations.  Table  I  shows  that  the 
inhibitory  action  of 60  #M  DRB  on  [3H]uridine 
incorporation  was  promptly  and  completely  re- 
versible upon  removal of the compound  from  the 
medium after a  60-rain period of treatment.  It was 
not necessary to incubate DRB-treated cultures for 
a  period of time in the absence of DRB to restore 
the  normal  rate  of RNA synthesis.  Such  restora- 
tion occurred immediately upon  removal of DRB, 
as determined  by pulse-labeling carried out during 
the  15  min  which  followed  the  removal  of  the 
inhibitor.  Similar  results  were  obtained  after  a 
treatment  period of 4  h.  In some experiments,  the 
medium  contained  5% fetal calf serum  during  the 
experiment.  Incorporation  of  [3H]uridine  was  in 
creased  approximately  twofold  in the presence of 
serum, but the degree of inhibition by 60 ~tM  DRB 
was  unchanged  (67%)  and  again  complete  and 
prompt  reversal  of  the  inhibition  was  obtained 
upon  removal  of  DRB  after  a  60-rain  period  of 
treatment.  Increased  uptake  of uridine upon  addi- 
tion  of serum  to confluent cultures  of mouse  3T3 
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stimulation observed in the present study occurred 
in  incomplete monolayers of L cells. 
NUCLEOPLASMIC  VS.  NUCLEOLAR  RNA 
SYNTHESIS:  To determine whether  DRB selec- 
tively  inhibits  nucleoplasmic  heterogenous  RNA 
synthesis,  L  cells  in  suspension  culture  were 
treated  with  DRB  for  15  rain  and  then  pulse- 
labeled  with  [3H]uridine  for  15  min in the contin- 
ued  presence  of the  compound.  Incorporation  of 
uridine  into  nucleoplasmic  and  nucleolar  RNA 
was  measured  at  DRB  concentrations  ranging 
from  12  to  150 t:M. 
Fig.  3  shows  that  12  uM  DRB  had  very little 
effect  on  the  incorporation  of  [SH]uridine  into 
nucleolar RNA while causing considerable inhibi- 
tion  of  nucleoplasmic  RNA  synthesis.  As  was 
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FIGURE 5  Relation between  concentration of DRB and 
effects  on  [SH]uridine  uptake  and  RNA  synthesis  in 
HeLa  cells.  Suspension  cultures  of  HeLa  cells  were 
started at a cell concentration of 1 x  105 cells/ml in the 
spinner modification of MEM with 7% calf serum. When 
the concentration reached 2 x  10 ~  cells/ml, the cells were 
collected  by  centrifugation,  washed  once  with  warm 
spinner  medium,  and  distributed  in  2-ml aliquots con- 
taining  0.4  x  10  e  cells/ml  in  small  plastic  tubes  in 
serum-free  spinner  medium  with  or  without  DRB  at 
varying  concentrations.  Three  cultures  were  used  per 
variable. The cells were incubated on a spinner wheel or 
shaker for 15 min and then [SH]uridine,  2.5 ~Ci/ml, was 
added  for a  pulse  of  15  min. The cells in each sample 
were  harvested  by  centrifugation,  and  processed  for 
determination  of total  uptake  of [SH]uridine  into cells 
and of incorporation of [SH]uridine into acid-precipitable 
material. The data were used to determine the inhibitory 
effect of DRB on RNA synthesis.  Mean results of three 
experiments are shown, except that the 90 ~.M DRB data 
points represent results of a single experiment. (O- -  O), 
Total cellular uptake  of [3H]uridine;  (-~  +),  RNA 
synthesis;  (O  .... 0),  incorporation  of [SH]uridine  into 
acid-precipitable material. 
6C 
4O 
demonstrated  above,  at  concentrations  up  to  12 
uM,  DRB  has  no  significant  effect on  uptake  of 
[SH]uridine into cells, and thus the results obtained 
at this concentration  and depicted in Fig. 3 clearly 
demonstrate the selective inhibitory effect of DRB 
on  nucleoplasmic  RNA synthesis.  At higher con- 
centrations, there is a quantitative difference in the 
inhibition  of  nucleoplasmic  and  nucleolar  RNA 
synthesis.  The  reduced  incorporation  of [3H]uri- 
dine into nucleoplasmic as well as nucleolar RNA 
at the higher concentrations of DRB can in part be 
explained  on  the  basis  of  reduced  uptake  of the 
precursor into cells. However, the findings suggest 
that  DRB at higher concentrations not only inhib- 
its  nucleoplasmic  RNA  synthesis  but also  has  an 
effect on  nucleolar  RNA synthesis.  Furthermore, 
even at very high concentrations  of DR B, such as 
150  uM,  nucleoplasmic  incorporation  of [3H]uri- 
dine  into  acid-precipitable  material  is  not  com- 
pletely inhibited. 
Fig.  4  presents  the  results  of  polyacrylamide- 
agarose  gel  electrophoresis  of  RNA  extracted 
from the nucleoplasmic and nucleolar fractions of 
control  and  12  #M  DRB-treated  L  cells  after 
pulse-labeling  for  15  min.  As  can  be  seen,  the 
nucleoplasmic RNA is heterogeneous and shows a 
broad  size  distribution,  while  the  predominant 
species in the nucleolar fraction is 45 S  ribosomal 
precursor RN A. The amount of the heterogeneous 
RNA in the nucleoplasmic fraction is considerably 
reduced in the DRB-treated  sample while the 45 S 
ribosomal  precursor  RNA  shows  little  if  any 
change after DRB treatment at  12 ~tM.  In individ- 
ual  experiments,  some  apparent  changes  were 
noted in the distribution  of heterogeneous nucleo- 
plasmic  RNA  among  different  size  classes  after 
DRB treatment,  but  the overall results of numer- 
ous  gel  analyses  indicated  no  systematic  and  re- 
producible changes  in the migration  profiles after 
15-min treatment  with DRB followed by a  15-min 
pulse in the continued presence of DRB. 
Action  of DRB  in HeLa  Cells 
DOSE-EFFECT  RELATIONSHIPS:  Fig.  5 
shows that,  in  HeLa cells,  DRB has a  marked ef- 
fect on the uptake of [3H]uridine into cells; e.g. 60 
,uM  DRB causes 60-70%  inhibition. Thus, uptake 
of  [3H]uridine  into  HeLa  cells is  inhibited  much 
more than that into L cells, and, therefore, correc- 
tion for this effect is essential in order to arrive at 
an estimate of inhibition of the rate of RNA syn- 
thesis  by  DRB  in  HeLa  cells,  particularly  in  the 
range above 10 uM DRB. RNA synthesis in HeLa 
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FIGURE 6  Time-course of action of DRB on ['H]uridine uptake and RNA synthesis in HeLa cells. 60-mm 
plastic plates were seeded with 2.5  ￿  l0  s HeLa cells per dish in reinforced Eagle's medium with 10% calf 
serum.  Approximately 24 h  later,  the  medium  was  removed,  the  plates were  washed  once with  warm 
reinforced  Eagle's  medium  and  the  incomplete  monolayer  cultures  incubated  with  30 /~M  DRB  and 
[SH]uridine.  At intervals, three experimental and three control cultures were collected and processed for 
determination of total uptake of [SHjuridine into ceils and incorporation of [aH]uridine into acid-precipita- 
ble material.  Mean results of three experiments are shown. (A) Total cellular uptake of [SH]uridine into 
acid-precipitable material: (A  A), control; (A  .... A), 30 ~M  DRB. (B) Incorporation of [3H]uridine 
into acid-precipitable material; (V  V), control; (V  .... V), 30 t*M DRB. (C) Effects of DRB expressed 
as  %  of control;  (O  .... O),  total uptake  of  [SH]uridine; (+  +),  RNA  synthesis; (O  .... O),  incor- 
poration of [SH]uridine into acid-precipitable material (cpm). 
TABLE  I I 
Reversibility of the Inhibitory Effect of 30 ~tM DR B on Uridine Incorporation in HeLa Cells in Monolayer 
Medium  [3HJUridine incorporation* 
During  Acid- 
Before  15-min  Acid-  precipitable/ 
pulse  pulse  Total  Acid-precipitable  precipitable  total 
%of  %of  ~o/ 
cpm  control  r  control  % of total  control 
Control  Control  60,782  100  5,568  100  9.2  100 
DRB, 60 rain  DRB  25,069  41  942  17  3.8  41 
DRB, 60 min  Control  56,493  92  5,656  101  10.0  109 
* 60-mm plastic plates were seeded with 2.5 ￿  lO  5 HeLa cells per dish in reinforced Eagle's medium with  10% calf 
serum. Approximately 24 h later, the medium was removed and the incomplete monolayers of HeLa cells were washed 
once with warm reinforced Eagle's medium. The plates were then incubated with or without 30#M DRB in reinforced 
Eagle's medium. For pulse-labeling, [aH]uridine (26.2 Ci/mmol) was used at a concentration of 2.5/~Ci/ml. After the 
pulse, the cultures were processed and the uptake of [SH]uridine into cells and the incorporation into acid-precipitable 
material were determined. The effect of DRB on RNA synthesis was calculated. 
cells  is  similar to  that  in  L  cells  in  sensitivity to 
inhibition by DRB (cf. Figs.  1 and 5). As in L cells. 
inhibition of RNA  synthesis in HeLa cells appears 
to  reach  a  plateau  at  higher  concentrations,  i.e. 
above 30 uM  DRB. 
No inhibition of HeLa cell protein synthesis was 
observed  in  the  concentration  range  of  DRB 
investigated, i.e.  12-60 uM.  In these experimentsl 
HeLa  cells  in  suspension  were  treated  with  DRB 
for  15  min  in  the presence  or  absence of 7% calf 
serum  and  then  pulse-labeled  for  15  rain  with 
[SH]leucine.  Comparable  cultures  received  [SH]- 
uridine.  While  the  presence  of  serum  resulted 
in  increases  in  incorporation  of  precursors  into 
acid-precipitable material (l.4-fold for [3H]leucine 
and  1.6-fold  for [3H]uridine), the inhibitory effect 
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closely  similar  in  the  presence  and  absence  of 
serum. 
KINETICS  OF  ACTION:  Fig.  6  A  shows 
that  uptake  of  [SH]uridine  into  HeLa  ceils  is 
markedly  reduced  after  a  2-min  treatment  with 
DRB.  Fig.  6  B  illustrates the very marked  reduc- 
tion in incorporation  of [SH]uridine into acid-pre- 
cipitable  material.  Fig.  6  C  demonstrates  that, 
after  correction  for the effect of DRB on  uridine 
uptake into HeLa cells, the degree of inhibition of 
RNA synthesis in HeLa cells is similar to that in L 
cells (See Fig. 2). 
REVERSIBILITY:  Table  11  shows  that  the 
inhibitory effect of 30 .M  DRB on  RNA synthe- 
sis in HeLa cells could be promptly and completely 
reversed  by  removal  of the  compound  from  the 
medium. The results also suggest that inhibition of 
uptake  of  uridine  into  cells  was  not  completely 
reversed within  15  min of removal of DRB. 
NUCLEOPLASMIC  VS.  NUCLEOLAR  RNA 
SYNTHESIS:  Fig. 7  shows results of determina- 
tions  of  incorporation  of  [SH]uridine  into  acid- 
precipitable  material  in  the  nucleoplasmic  and 
nucleolar  fractions  of  HeLa  cells  in  suspension 
culture. While the effect on nucleoplasmic incorpo- 
ration  is greater,  there is also considerable inhibi- 
tion  of incorporation  of [SH]uridine  into  the  nu- 
cleolar  fraction,  which  is discussed  below.  These 
effects  increase  markedly  in  the  concentration 
range  from  5  to  30  ~M,  but  level  off at  higher 
concentrations,  as was noted above for the inhibi- 
tion of the overall rate of RNA synthesis in HeLa 
cells (cf.  Fig. 5). 
Fig.  8  shows  the  results  of polyacrylamide  gel 
analysis of RNA in the nucleoplasmic and nucleo- 
lar fractions from HeLa cells, in the nucleoplasmic 
fraction  the  RNA  shows  a  broad  distribution 
characteristic of the nuclear heterogeneous RNA, 
while  the  RNA  from  the  nucleolar  fraction  is 
predominantly 45 S  ribosomal precursor RNA.  12 
,M  DRB reduced  the amount of labeled RNA in 
both fractions,  but,  as expected, the reduction was 
greater  in  the  nucleoplasmic  fraction.  No  signifi- 
cant changes were observed in the size distribution 
of RNA species after treatment of cells with DRB. 
DISCUSSION 
An examination of the effects of DRB in the L-929 
line of mouse fibroblasts and in the HeLa $3 line 
of  human  carcinoma  cells  has  shown  that  the 
inhibitory  action  of  this  compound  on  RNA 
synthesis  is  immediate  and  promptly  reversible 
upon removal of the compound from the medium. 
In  L  cells, DRB has only a  minor effect on the 
uptake of [3H]uridine into cells. The dose-response 
curves  show  that  a  part  of the  process  of  RNA 
synthesis  is highly sensitive to DRB while another 
part  is  resistant  to  the  action  of  DRB.  This 
difference  arises  mainly  from  the  fact  that  the 
synthesis of nucleoplasmic heterogeneous RNA is 
more  sensitive  to  inhibition  than  the  synthesis  of 
nucleolar  ribosomal  precursor  RNA. At low con- 
centrations  such  as  12  #M  (3.8  #g/ml),  DRB 
reduced  by approximately 40% the rate of synthe- 
sis of nucleoplasmic heterogeneous RNA in L cells 
in the absence  of a  significant effect on  nucleolar 
RNA synthesis. 
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FIGURE 7  Effects of DRB on nucleoplasmic and nucleo- 
lar RNA synthesis  in HeLa cells. HeLa ceils were grown 
in  suspension  culture  in  spinner  medium  with  7% calf 
serum. The starting concentration was I  ￿  105 cells/ml, 
and,  when  the  cell count  had  doubled,  the  cells were 
collected  by  ccntrifugation,  washed  once  with  warm 
spinner  medium,  resuspendcd  and distributed  at 0.8  ￿ 
106 cclls/ml into six tubes (1.6  ￿  107 cells/aliquot) in 20 
ml of serum-free medium without DRB or with DRB at 
varying concentrations. The cells were incubated at 37~ 
for  15  min,  and  then  [SH]uridine  was  added  to  a 
concentration of 15 ~Ci/ml. After labeling for  15 min, 
the  ceils  were  harvested  on  ice,  collected  by  centrif- 
ugation,  and  washed  once  with  PBS.  The  nuclei  and 
subsequently  the nucleoplasmic and  nucleolar fractions 
were  isolated  as described  in  Materials  and  Methods. 
Incorporation of [aH]uridine  into the nucleoplasmic and 
nucleolar fractions was measured by scintillation count- 
ing.  Results  of  14  experiments  are  shown.  In  the 
untreated controls, the mean radioactivity in the nucleo- 
plasmic fraction was 4,044,700  cpm and in the nucleolar 
fraction it was 3,144,600 cpm. (I----I),  Nucleoplasmic 
fraction; (A  .... &), nuclcolar fraction. The vertical bars 
indicate probable error for data points. 
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FIGURE 8  Effects  of DRB on the synthesis of nuclear heterogeneous and ribosomal precursor RNA in 
HeLa cells. The experimental conditions are given in Fig. 7. The isolation of nucleoplasmic and nucleolar 
fractions and of RNA from such fractions as well as the procedure for acrylamide gel electrophoresis are 
described in Materials and Methods. (A) Nucleoplasmic RNA, control; (B) nucleolar RNA, control; (C) 
nucleoplasmic RNA,  12/zM DRB; (D) nucleolar RNA,  12 gM DRB. 
Our results also show,  however, that  not all of 
the  heterogeneous  RNA  in  the  nucleoplasmic 
fraction of L cells is highly sensitive to inhibition 
by DRB and, furthermore, that the synthesis of the 
45  S  preribosomal  RNA  is  partially sensitive to 
the  inhibitory action  of  DRB  at  concentrations 
higher than  12 #M. The finding that the synthesis 
of  a  part  of the  heterogeneous  nuclear RNA  is 
resistant  to  inhibition  by  DRB  is  difficult  to 
explain as an experimental artifact due to contami- 
nation  with  nucleolar material,  because  even  at 
very  high  concentrations of DRB  the  pattern  of 
size  distribution of  the  heterogeneous  RNA  re- 
mains essentially unaltered. If there were  present 
in the  nucleoplasmic RNA  fraction a  substantial 
amount of 45 S ribosomal precursor RNA whose 
synthesis  was  resistant  to  DRB,  such  material 
should become apparent in acrylamide gel analysis 
of the nucleoplasmic fraction, when the synthesis 
of heterogeneous RNA is markedly depressed by 
high doses of DRB.  It is more likely that among 
the  nucleoplasmic heterogeneous  RNA  there  is 
some  whose  synthesis is  resistant to  DRB.  Our 
data  are  compatible with  the view  that  this sub- 
fraction contains RNA belonging to the broad size 
range of nuclear heterogeneous RNA. Work is in 
progress  to determine the  chemical properties of 
the DRB-sensitive and DRB-resistant nuclear het- 
erogeneous RNA. 
Recent evidence indicates that DRB can mark- 
edly inhibit interferon mRNA synthesis (24).  We 
propose that DRB may have greatest effect  on the 
synthesis of that portion of nuclear heterogeneous 
RNA which  is precursor to mRNA. If DRB acts 
at the polymerase level, then the possibility arises 
that  there  may  be  more  than  one  polymerase 
involved in the synthesis of nuclear heterogeneous 
RNA. 
It is also difficult to explain the inhibition  of the 
synthesis of some of the ribosomal precursor RNA 
in the molecular fraction of L cells as an experi- 
mental  artifact,  because  this  material  is  very 
clearly  and  sharply  resolved  by  acrylamide  gel 
analysis  and-shows  a  substantial decrease  after 
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Comparison  of the Effects of lSO aM DRB in L-929 
and HeLa $3 Cells; Rates of [sH]Uridine  Uptake, 
Incorporation  into  Acid-precipitable  Material, and 
RNA  Synthesis  Expressed  as  Percent  of Control 
Rates* 
L-929 cells  HeLa $3 cells 
(total uptake = 51)  (total uptake = 12) 
Nucleo-  Nucleo- 
plasmic  Nucleolar  plasmic  Nucleolar 
Acid-precipitable  15  30  5  8 
incorporation 
RNA synthesis  31  63  25  40 
* Cells treated with DRB for 15 rain and then pulse-labeled  with 
[~H]uridine for 15 min in the continued presence of DRB. 
treatment of L  cells with DRB at high concentra- 
tions.  However,  the  apparent  reduction  in  the 
overall  rate  of  RNA  synthesis  in  the  nucleolar 
fraction  may  in  part  reflect  contamination  with 
heterogeneous RNA  (26). 
Table  III  presents  a  summary  of comparative 
data on the effects of  150 uM  DRB in  L-929  and 
HeLa $3 cells. The inhibitory effect of DRB on the 
uptake of uridine is much greater in HeLa than in 
L  cells.  The  reduction  in  the  rate  of  nuclear 
heterogeneous  RNA  synthesis is similar in  DRB- 
treated  HeLa  and  L  cells.  In  HeLa  cells,  as  in  L 
cells,  there  appears  to  be  some  heterogeneous 
nuclear RNA whose synthesis is resistant to inhibi- 
tion  by  DRB.  The  apparent  effect  of  DRB  on 
nucleolar  RNA  synthesis is greater in  HeLa than 
in  L  cells;  however,  results  of  acrylamide  gel 
analysis (cf. Figs. 4 and 7) suggest that this may be 
due  to  greater  contamination  of  the  nucleolar 
fraction with heterogeneous RNA  in  HeLa cells. 
The present studies show that, at the appropriate 
dose level,  DRB  is a  selective inhibitor of nuclear 
heterogeneous RNA synthesis in mammalian cells. 
The compound has a  similar action in insect (8, 9) 
and  avian cells (14)  and  may  therefore  be widely 
useful  as  a  probe  in  studies  of various  aspects  of 
RNA  metabolism.  These  include  investigation of 
the  initiation  mechanism  of  RNA  transcription, 
studies  of processing  of  RNA,  definition  of sub- 
classes of nuclear heterogeneous RNA,  and inves- 
tigation of regulation  of cellular biosynthetic pro- 
cesses. 
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